Quick Answer
Rani Therapeutics Holdings, Inc. reported Total Assets of $58.62 million for fiscal year 2025.
Rani Therapeutics Holdings, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $58.62M | +60.0% |
| 2024 | $36.63M | -36.7% |
| 2023 | $57.92M | -46.4% |
| 2022 | $108.03M | -13.0% |
| 2021 | $124.21M | +56.4% |
| 2020 | $79.42M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $10.14M | -76.7% | -40.0% |
| June 30, 2025 | $16.90M | -61.4% | -30.0% |
| March 31, 2025 | $24.12M | -54.9% | -34.1% |
| December 31, 2024 | $36.63M | -36.7% | -15.9% |
| September 30, 2024 | $43.54M | -38.2% | -0.4% |
| June 30, 2024 | $43.73M | -47.6% | -18.3% |
| March 31, 2024 | $53.51M | -44.5% | -7.6% |
| December 31, 2023 | $57.92M | -46.4% | -17.8% |
- Rani Therapeutics Holdings, Inc. showed an increase of +60.0% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, Rani Therapeutics Holdings, Inc.’s total assets has declined by 26.2% (from $79.42 million to $58.62 million).
- The most recent figure is from Rani Therapeutics Holdings, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: